ClinicalTrials.gg
RecruitingNCT07667998HILTUpdated Nov 4, 2026

High-intensity Laser Therapy Versus Extracorporeal Shock Wave on Tendon Thickness and Occupation Ratio In Patients With Chronic Supraspinatus Tendinopathy

An interventional study of High-intensity Laser Therapy and Extracorporeal Shock Wave in Supraspinatus Tendinopathy, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Updated Nov 4, 2026Now RecruitingFirst site in Egypt+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
69
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Tendinopathy by Cairo University — 4 open to participants now, 4 under way, none of them phase 3. Tendinopathy · Cairo University.

Planned enrollment
Largest of 10
69 · median 50
Started
2026
with 1 other
No phase
10 of 10
4 open now
Registered
9th of 10
by date

Among the 10 studies in Tendinopathy by Cairo University, this one has the largest planned enrollment, is one of 2 that started in 2026, is one of 10 with no phase, and was the 9th registered.

Tendinopathy

399 studies on the registry are indexed under Tendinopathy; 77 are open to participants now.

Browse Tendinopathy studies →

Open to participants now

4 of the 10 studies in Tendinopathy by Cairo University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 46 Tendinopathy studies recruiting now, 17 (37%) set no upper age limit and 22 (48%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Tendinopathy by Cairo University, or all of them as a file.
02

Study summary

This study will be conducted to investigate the difference between high-intensity laser and extracorporeal shock wave on supraspinatus tendon thickness, subacromial space, occupation ratio, shoulder pain intensity, shoulder range of motion (ROM), hand strength, and functional disability in patients with chronic supraspinatus tendinopathy.

Read the detailed description

Supraspinatus tendinopathy is a common cause of shoulder pain and dysfunction due to irritation, inflammation, or degeneration of the supraspinatus tendon in the rotator cuff. It is caused by repetitive overhead movements and is characterized by pain, weakness, and a limited range of motion, especially when reaching or lifting the arm. Recently, studies have demonstrated that HILT is useful for treating a variety of shoulder impairments, including subacromial impingement syndrome, rotator cuff tendinopathy, and adhesive capsulitis.Shock wave is an effective and noninvasive method of reducing pain and increasing ROM and functional status without the need for surgery; it has been successfully utilized to treat tendinopathy over the past 20 years.There is a gap in available literature about comparing the high-intensity laser and extracorporeal shock wave in patients withchronic supraspinatus tendonitis. So this study may add a piece of information to the physiotherapists in the government hospitals and the private clinics about showing the difference between the application of High Intensity laser and extracorporeal shock wave in patients with chronic supraspinatus tendinitis

03

Conditions studied

  • Supraspinatus Tendinopathy

Browse trials for

Keywords

  • High-intensity Laser Therapy
  • Extracorporeal Shock Wave
  • Tendon Thickness
  • Chronic Supraspinatus Tendinopathy
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients from 18 to 50 years old of both genders.
  • Unilateral Chronic Supraspinatus Tendinitis in dominant side
  • 18.5-24.9
  • Tenderness is found over the supraspinatus as it passes subacromial and anterolateral The patient will report pain with active shoulder elevation in the scapular plane (eg: welders, plate workers, slaughterhouse workers and overhead playing athletes)
  • The patient will report pain with resisted isometric abduction.
  • The patient will report positive Jobe's test (empty can test)

Exclusion criteria

Exclusion Criteria:

  • Post shoulder surgery, traumatic incidents
  • Partial tears at surgery
  • Massive retracted tears at surgery
  • Frozen shoulder Rotator cuff tear
  • Glenohumeral or acromioclavicular arthritis
  • Implanted pacemaker
  • Pregnancy
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
69 participants (estimated)

Study arms

  • Experimental
    High-intensity Laser Therapy

    Twenty-three patients with chronic supraspinatus tendinopathy will receive high-intensity laser and conventional physiotherapy twice a week for six weeks

    Other: High-intensity Laser Therapy · Other: conventional therapy

  • Experimental
    Extracorporeal Shock Wave

    Twenty-three patients with chronic supraspinatus tendinopathy will receive extracorporeal shock wave and conventional physiotherapy twice a week for six weeks

    Other: Extracorporeal Shock Wave · Other: conventional therapy

  • Active comparator
    conventional therapy

    Twenty-three patients with chronic supraspinatus tendinopathy will receive conventional physiotherapy twice a week for six weeks

    Other: conventional therapy

Interventions

  • OtherHigh-intensity Laser Therapy

    the patients will receive HILT with peak power 3kW, intensity 15000W/cm and energy per pulse 350 mj) at supraspinatus tendenopathy.The treatment consisted of 3 phases in each session. the initial phase will be rapid manual scanning (100 cm2/30s) of the anterior joint line of the shoulder with one shot of 850 mj at frequency of 30 Hz. The scanning will be performed parallel to the joint line, with the patient arm internally rotated on the posterior scan and externally rotated on the anterior scan. the intermediate phase will be a fixed scan phase , with one -shot emission of 350mj at a frequency of 20-25Hz. plus conventional therapy

  • OtherExtracorporeal Shock Wave

    patients will be sitting with shoulder abduction at 45 and elbow flexed and the forearm rested on flat surface and shock wave applicator directed in the most tender point near the insertion at the greater tubrosity under acromion with 2000 impulses, and energy flex density of 0.22mj/mm , pulse rate 10/sec and frequency 1-15 Hz plus conventional therapy

  • Otherconventional therapy

    will receive Conventional physical therapy in form of stretching exercise of posterior shoulder capsule, passive stretching exercise, will be done only 3 times with holding time 30 sec and 10 sec rest period between repetitions , strengthing exercise consists of 3 exercises all have been recommended as essential for any shoulder rehabilitation program. These exercise include shoulder flexion, scaption and horizontal extension. for each exercise, a 10-repetition maximum for 3 sets with 60 sec rest between every set + TENS and hot back.

06

What researchers measure

Primary outcomes

  1. supraspinatous tendon thickness

    supraspinatus tendon thickness will be assess by ultrasonography.The tendon often appears swollen or thickened (frequently \> 6 to 7 mm)

    Time frame: up to 6 weeks

  2. supracromial space

    supracromial space will be measured by ultrasonography. A normal resting subacromial space generally ranges from 9 to 11 mm. A measurement of less than 6 mm is often pathological

    Time frame: up to 6 weeks

  3. occupation ratio of subacromial space

    The ratio comparing the thickness of the supraspinatus tendon to the overall acromiohumeral distance. An increased occupation ratio (i.e., a thickened tendon taking up too much of the space) indicates a higher risk of impingement

    Time frame: up to 6 weeks

Secondary outcomes

  1. pain intensity

    visuala analogue scale will be used to assess pain intesity. it is a line of 100 mm.The ends are labeled with extremes, such as "No pain" at 0 mm and "Worst pain imaginable" at 100 mm.

    Time frame: up to 6 weeks

  2. shoulder range of motion

    the range of motion will be measured by electrogoniometer

    Time frame: up to six weeks

  3. upper limb disability

    The QuickDASH will be used to assess upper limb function.the QuickDASH is an 11-item questionnaire used to measure physical function and symptoms in people with upper limb disorders. Scores range from 0 (no disability) to 100 (most severe disability).

    Time frame: up to six weeks

  4. supraspinatus muscle strength

    supraspinatus muscle strength will be measured by handheld dynamometer

    Time frame: up to six weeks

07

Study locations

1 of 1 sites recruiting
  • Cairo University - faculty of physical therapy outpatient clinic
    Cairo, Egypt
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Apr 2027, 9 months after the start.

Of 174 non-industry interventional studies with no phase under Tendinopathy, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 38. This study's planned 9 months is below that.

Counting every sponsor, half of 183 studies reached it within 20 months; a quarter within 7 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 19, 2026
First posted
Jun 25, 2026
StartActual
Jun 30, 2026
Primary completionEst.
Apr 25, 2027
CompletionEst.
Apr 25, 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 4, 2026
Sites
1 site added — first site in Egypt
Show site
  • Cairo University - faculty of physical therapy outpatient clinic · Cairo, Egypt
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Egypt
    Show site
    • Cairo University - faculty of physical therapy outpatient clinic · Cairo, Egypt
    + 1 other change: date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07667998
Lead sponsor
Cairo University
Responsible party
Mahmoud Mamdouh Ahmed Shaaban (principle investigator : mahmoud mamdouh ahmed shaaban, Cairo University) — Principal investigator
First posted
Jun 25, 2026
Start date
Jun 30, 2026
Primary completion
Apr 25, 2027 (estimated)
Completion
Apr 25, 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

mahmoud shaaban, phd
Contact
shaabab.m@outlook.com
01001080842

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion